Resistance to piperacillin/tazobactam in Escherichia coli resulting from extensive IS26-associated gene amplification of blaTEM-1

被引:44
作者
Hansen, Katrine Hartung [1 ]
Andreasen, Minna Rud [1 ,2 ]
Pedersen, Martin Schou [1 ]
Westh, Henrik [1 ,3 ]
Jelsbak, Lotte [2 ]
Schonning, Kristian [1 ,3 ]
机构
[1] Hvidovre Univ Hosp, Dept Clin Microbiol 445, Hvidovre, Denmark
[2] Roskilde Univ, Dept Sci & Environm, Roskilde, Denmark
[3] Univ Copenhagen, Fac Hlth & Med Sci, Dept Clin Med, Copenhagen, Denmark
关键词
OXA-1; BETA-LACTAMASE; SUSCEPTIBILITY; EVOLUTION; STRAINS; TRENDS;
D O I
10.1093/jac/dkz349
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Background: bla(TEM-1) encodes a narrow-spectrum beta-lactamase that is inhibited by beta-lactamase inhibitors and commonly present in Escherichia coli. Hyperproduction of bla(TEM-1) may cause resistance to penicillin/beta-lactamase inhibitor (P/BLI) combinations. Objectives: To characterize EC78, an E. coli bloodstream isolate, resistant to P/BLI combinations, which contains extensive amplification of bla(TEM-1) within the chromosome. Methods: EC78 was sequenced using Illumina and Oxford Nanopore Technology (ONT) methodology. Configuration of bla(TEM-1) amplification was probed using PCR. Expression of bla(TEM-1) mRNA was determined using quantitative PCR and beta-lactamase activity was determined spectrophotometrically in a nitrocefin conversion assay. Growth rate was assessed to determine fitness and stability of the gene amplification was assessed by passage in the absence of antibiotics. Results: Illumina sequencing of EC78 identified bla(TEM-1B) as the only acquired beta-lactamase preceded by the WT P3 promoter and present at a copy number of 182.6 with bla(TEM-1B) bracketed by IS26 elements. The chromosomal location of the IS26-bla(TEM-1B) amplification was confirmed by ONT sequencing. Hyperproduction of bla(TEM-1) was confirmed by increased transcription of bla(TEM-1) and beta-lactamase activity and associated with a significant fitness cost; however, the array was maintained at a relatively high copy number for 150 generations. PCR screening for bla(TEM) amplification of isolates resistant to P/BLI combinations identified an additional strain containing an IS26-associated amplification of a bla(TEM) gene. Conclusions: IS26-associated amplification of bla(TEM) can cause resistance to P/BLI combinations. This adaptive mechanism of resistance may be overlooked if simple methods of genotypic prediction (e.g. gene presence/absence) are used to predict antimicrobial susceptibility from sequencing data.
引用
收藏
页码:3179 / 3183
页数:5
相关论文
共 19 条
[1]   High Fitness Costs and Instability of Gene Duplications Reduce Rates of Evolution of New Genes by Duplication-Divergence Mechanisms [J].
Adler, Marlen ;
Anjum, Mehreen ;
Berg, Otto G. ;
Andersson, Dan I. ;
Sandegren, Linus .
MOLECULAR BIOLOGY AND EVOLUTION, 2014, 31 (06) :1526-1535
[2]   Estimating National Trends in Inpatient Antibiotic Use Among US Hospitals From 2006 to 2012 [J].
Baggs, James ;
Fridkin, Scott K. ;
Pollack, Lori A. ;
Srinivasan, Arjun ;
Jernigan, John A. .
JAMA INTERNAL MEDICINE, 2016, 176 (11) :1639-1648
[3]   Epidemiology of Bloodstream Infections Caused by Escherichia coli and Klebsiella pneumoniae That Are Piperacillin-Tazobactam-Nonsusceptible but Ceftriaxone-Susceptible [J].
Baker, Thomas M. ;
Rogers, Wesley ;
Chavda, Kalyan D. ;
Westblade, Lars F. ;
Jenkins, Stephen G. ;
Nicolau, David P. ;
Kreiswirth, Barry N. ;
Calfee, David P. ;
Satlin, Michael J. .
OPEN FORUM INFECTIOUS DISEASES, 2018, 5 (12)
[4]   IRT and CMT β-lactamases and inhibitor resistance [J].
Canton, R. ;
Morosini, M. I. ;
Martin, O. ;
de la Maza, S. ;
de la Pedrosa, E. Gomez G. .
CLINICAL MICROBIOLOGY AND INFECTION, 2008, 14 :53-62
[5]   Longitudinal trends and cross-sectional analysis of English national hospital antibacterial use over 5 years (2008-13): working towards hospital prescribing quality measures [J].
Cooke, Jonathan ;
Stephens, Peter ;
Ashiru-Oredope, Diane ;
Charani, Esmita ;
Dryden, Mathew ;
Fry, Carole ;
Hand, Kieran ;
Holmes, Alison ;
Howard, Philip ;
Johnson, Alan P. ;
Livermore, David M. ;
Mansell, Paula ;
McNulty, Cliodna A. M. ;
Wellsteed, Sally ;
Hopkins, Susan ;
Sharland, Mike .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2015, 70 (01) :279-285
[6]   International dissemination of Escherichia coli strains with discrepant behaviour in phenotypic antimicrobial susceptibility tests [J].
Creely, D. ;
Zambardi, G. ;
van Belkum, A. ;
Dunne, Wm M., Jr. ;
Peyret, M. ;
Gayral, J. P. ;
Shortridge, D. ;
Shubert, C. .
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 2013, 32 (08) :997-1002
[7]   Movement of IS26-Associated Antibiotic Resistance Genes Occurs via a Translocatable Unit That Includes a Single IS26 and Preferentially Inserts Adjacent to Another IS26 [J].
Harmer, Christopher J. ;
Moran, Robert A. ;
Hall, Ruth M. .
MBIO, 2014, 5 (05)
[8]   Temocillin and piperacillin/tazobactam resistance by disc diffusion as antimicrobial surrogate markers for the detection of carbapenemase-producing Enterobacteriaceae in geographical areas with a high prevalence of OXA-48 producers [J].
Huang, Te-Din ;
Poirel, Laurent ;
Bogaerts, Pierre ;
Berhin, Catherine ;
Nordmann, Patrice ;
Glupczynski, Youri .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2014, 69 (02) :445-450
[9]   Promoters P3, Pa/Pb, P4, and P5 upstream from blaTEM genes and their relationship to β-lactam resistance [J].
Lartigue, MF ;
Leflon-Guibout, W ;
Poirel, L ;
Nordmann, P ;
Nicolas-Chanoine, MH .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2002, 46 (12) :4035-4037
[10]   OXA-1 β-lactamase and non-susceptibility to penicillin/β-lactamase inhibitor combinations among ESBL-producing Escherichia coli [J].
Livermore, David M. ;
Day, Michaela ;
Cleary, Paul ;
Hopkins, Katie L. ;
Toleman, Mark A. ;
Wareham, David W. ;
Wiuff, Camilla ;
Doumith, Michel ;
Woodford, Neil .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2019, 74 (02) :326-333